Aim: Using vagus nerve stimulation (VNS), the aim of this study was to determine the 38 between direct activation of descending efferents against afferent-induced decreases in central 61 parasympathetic drive to the heart. With increasing current, VNS first activates afferent fibers 62 followed by descending parasympathetic efferent fibers, interactions that maintain cardiac 63 stability. 64 65
right VNTx (1.69±0.17 mA for right and 3.04±0.27 mA for left), decreasing further following 48 bilateral VNTx (1.29±0.16 mA for right and 1.74±0.19 mA for left). Similar effects were observed 49 following left VNTx. The thresholds for afferent-mediated effects on cardiac parameters were 50 0.62±0.04 mA and 0.65±0.06 mA with right and left VNS, respectively, and reflected primarily as 51 augmentation. Afferent-mediated tachycardias were maintained following beta-blockade, but 52 eliminated by VNTx. Conclusions: The increased effectiveness and decrease in bradycardia 53 threshold with sequential VNTx suggests that (1) vagal afferents inhibit centrally-mediated 54 parasympathetic efferent outflow and (2) the ipsilateral and contralateral vagi exert a substantial 55 buffering capacity. The intact threshold reflects the interaction between multiple levels of the 56 cardiac neural hierarchy. 57
INTRODUCTION 68
Cardiac control is a manifestation of a neural hierarchy that may be considered in three 69 levels (9, 21, 33). Level 1 comprises the spinal cord and medulla as modulated by higher 70 centers (1, 16, 27, 38) . Level 2 comprises extracardiac-intrathoracic neurons including the 71 stellate, middle cervical and mediastinal ganglia (4, 6, 8). Level 3 involves the intrinsic cardiac 72 nervous system (9). The peripheral levels (2 and 3) form cardio-centric control loops, while the 73 central nervous system (Level 1) engages neural mechanisms for both cardiac and peripheral 74 vasculature regulation (33, 60). Acting together, these hierarchical populations coordinate and 75 regulate regional cardiac electrical, mechanical and metabolic indices throughout each cardiac 76 cycle (7, 9, 12). Endogenous or exogenous stresses have the potential to impact multiple levels 77 of this hierarchy (19, 21, 32, 60) . It is through the understanding of such hierarchical control and 78
how it adapts to acute and chronic stress that rationale, mechanistic-based approaches can be 79 devised to target the cardiac neural hierarchy in order to manage cardiovascular pathology (14, 80
19, 21). 81
The vagus nerve is a complex neural structure, containing descending efferent 82 parasympathetic fibers and ascending afferent fibers. Efferent parasympathetic fibers modulate 83 several cardiac indices including chronotropy, dromotropy, inotropy and lusitropy (46, 48) . The 84 majority of fibers (approximately 80%) contained within the vagus are afferent (sensory) in 85 nature (13, 42). Thus, the vagus nerve is an important pathway that carries sensory information 86 from visceral organs, including the heart, to the central nervous system. There is also structural 87 8 comparison was used for analysis of threshold. P<0.05 was considered to be statistically 172 significant. Statistical analyses were performed with JMP Pro v11.2 (SAS Institute Inc., Cary, 173 NC, USA). 174
RESULTS

176
VNS impacted multiple indices of cardiac electrical and mechanical function. Figure 1  177 shows a typical example of the response to right VNS at intensity sufficient to impose acute 178 changes in cardiovascular function. Note the VNS-evoked decrease in heart rate, systemic (BP) 179 and left ventricular pressure (LVP) as well as LV dp/dt maximum and LV dp/dt minimum. At 180 VNS offset, all the indices recovered rapidly to baselines values with a potential to transiently 181 overshoot baseline values, especially at higher current and frequency levels. Figure 3 shows the corresponding heart rate 188 levels at baseline and in response to right-sided VNS following first ipsilateral (panel A) or 189 contralateral (panel B) VNTx and then followed by bilateral VNTx. In the intact state, right VNS 190 produce tachycardia at lower currents (starting at ~0.25-0.50 mA) and bradycardia at higher 191 currents (Figure 2A and 2B; Figure 3A and 3B). The augmentor effects on HR produced at 192 lower currents were eliminated following ipsilateral but not contralateral VNTx ( Figure 2A and 193 2B; Figure 3A and 3B). Right-sided VNS following either ipsilateral or contralateral VNTx 194 resulted in greater reductions in HR, LV dp/dt maximum and LV dp/dt minimum compared to the 195 ( Figure 4A and 4B). In the intact state, left VNS resulted in negligible changes in LV dp/dt 206 maximum and minimum, even at currents up to 4.0 mA ( Figure 4C-4F ). Following ipsilateral, but 207 not contralateral VNTx, left VNS reduced HR, LV dp/dt maximum and LV dp/dt minimum 208 Bradycardia threshold was defined as the current required to first produce a 5% decrease in 214 mean HR during the 14s of VNS. VNS was delivered at 10Hz and pulse width of 500 μs. In the 215 right-sided protocol in the intact state, threshold for the right vagus nerve was 2.91±0.18 mA 216 and for the left vagus nerve it was 3.47±0.20 mA ( Figure 5A) Figure 3) . 240
Central-peripheral neural network interactions with vagus nerve stimulation: effects of 241 frequency 242
After determining thresholds in the intact state, the effects of VNS on chronotropy, as well 243 as LV inotropy and lusitropy, were evaluated over a range of frequencies (2-30 Hz) while 244 maintaining the same current (1.2x bradycardia threshold determined at 10 Hz) and pulse width 245 (500 μs). Figure 6 shows the percent changes in chronotropy, LV inotropy and LV lusitropy in 246 response to left VNS across a range of frequencies in the intact state, following left VNTx or 247 right VNTx, and then following bilateral VNTx. In all states, increasing frequency resulted in 248 greater reductions in HR, LV dp/dt maximum and LV dp/dt minimum. Left VNS following either 249 ipsilateral or contralateral VNTx resulted in a greater reduction in all measured indices 250 compared to the intact state (p<0.0001), with the exception of LV dp/dt maximum following 251 ipsilateral VNTx. There was an even further reduction in these indices with left VNS following 252
bilateral VNTx compared to the intact state (p<0.0001), as well as compared to ipsilateral 253 (p<0.0001) or contralateral VNTx (p<0.0001). 254 In the present study, we also demonstrate that the VNS bradycardia threshold, specifically 342 the output current required to first produce a minimum defined (5%) decrease in HR, reflects the There are multiple hypotheses to explain observed decreases in threshold. The first reflects 359 the role of vagal afferent axons in reflexly modulating parasympathetic efferent outflows to the 360 heart. Our data indicate that activated vagal afferents initiate centrally-mediated reflexes that 361 inhibit parasympathetic efferent outflows to the heart. As such, the level of activity on a given 362 parasympathetic postganglionic neuron would reflect not only diminished endogenous central 363 drive, but also inputs arising from direct electrical activation of parasympathetic efferent fibers. 364
Since both vagi project to neurons throughout the ICNS (5, 9), this would have the net effect of 365 shifting the VNS chronotropic response surface/curve to the right. A second hypothesis is that 366 bioelectrical stimulation of the cervical vagosympathetic trunk activates axons projecting to the 367 LCNs in the ICNS that, in turn, inhibit the direct pre-to postganglionic parasympathetic neuron 368 pathways (31). We have previously demonstrated that similar inputs to the ICNS can initiate 369 directionally opposite responses from adjacent intrinsic cardiac neurons that reflect this potential 370 (12). In the context of the current study, this proposed descending direct inhibitory mechanism is 371 unlikely to be functionally important since it should also occur following unilateral VNTx and, as 372 such, response surfaces would not have shifted, as was observed in this study. A thirdthe ICNS and at the end-effectors (39, 45). Such a mechanism would, at best, represent a minor 375 component, as reflected in the minimal changes observed with VNS in the presence of beta 376 adrenergic blockade. However, the fall in LV and systemic blood pressure following bilateral 377
VNTx may be reflective of a tonic sympathetic component for cardiovascular control mediated 378 by axonal projections contained within the cervical vagosympathetic complex or alterations in 379 integrated reflex control resulting from the loss of afferent inputs. A fourth possibility is that 380
VNTx alters the neural interactions/balance for control of the sinoatrial nodal complex (39). In 381 this regard, a similar mechanism could also occur within other intrinsic cardiac local circuit 382 neuronal populations regulating atrial and/or ventricular contractile function (15, 56). Future 383 experiments will be required to explore these hypotheses. 384
Inotropic and lusitropic control: Integrated parasympathetic control of atrial, atrioventricular 385
and ventricular function is mediated via parasympathetic preganglionic inputs to the distributed 386 network of interdependent intrinsic cardiac ganglionated plexi (9, 15, 57). While earlier work 387 suggested that vagal restraint on inotropic function is manifest against an enhanced 388 sympathetic background (e.g., accentuated antagonism) (34, 35), later work has demonstrated 389 that activation of the ICNS, either endogenously or exogenously, impacts cardiac contraction 390 and relaxation directly (15, 44, 56). As is evident from the VNS intensity plots depicted herein 391 (Figures 2-4) , with intact vagi the magnitude of the evoked inotropic and lusitropic responses 392 are moderate (approximately 5% of baseline). Subsequent to VNTx, responses evoked in 393 ventricular contractility were shifted to the left -to substantially greater levels. This shift is 394 likewise evident when a fixed output current was applied (Figs. 6 and 7) , where even at the 395 lowest frequency (2 Hz), the minimal change in contractility evoked in the intact state 396 transitioned to a 15-25% decreases following bilateral VNTx. These data demonstrate that in the 397 intact state the neuronal hierarchy for cardiac control has a substantial buffering capacity that 398 acts reflexly to maintain cardiac stability in the face of endogenous and exogenous stresses, 399 including those induced by VNS itself. 400
Differential effects of VNS on autonomic efferent outflows 401
Parasympathetic and sympathetic divisions of the autonomic nervous system cannot be 402 considered in isolation as they function as interdependent components of the cardiac neuronal 403 hierarchy (9, 21, 59). As such, changes in autonomic efferent outflow in response to VNS 404 
VNS and the neural fulcrum 415
When considering stimulation parameters necessary for VNS therapy one must be 416 cognizant of not only the anatomic/functional characteristics of the axons being stimulated 417 therein (afferent/efferent axons), but also the effects of direct vs. reactive changes that result 418 from the whole cardiac neuronal hierarchy attempting to maintain stability of cardiovascular 419 function (14). Since the cardiac hierarchy normally acts as a negative feedback system, 420 perturbing the system in one direction evokes a corresponding reflex response in the opposite 421 direction to maintain stability. The greater the perturbation, the greater the reflex response and 422 the greater the instability of the entire system. 423
As such, we propose that the optimum therapeutic parameters for cervical VNS therapy are 424 at the point at which afferent and efferent fibers are activated in a balanced manner. That is, 425 when afferent driven decreases in central parasympathetic drive are counteracted by direct 426 activation of the cardiac parasympathetic efferent projections to the ICNS and heart -the net 427 result of which being a null HR response (2, 31). We define this point as the neural fulcrum. 428 VNS performed near this neural fulcrum operates within the normal constraints of the cardiac 429 neuronal hierarchy, without evoking reactive changes that occur when high currents and/or 430 frequencies are utilized (31). At this neural fulcrum it should be recognized that both central and 431 peripheral aspects of the cardiac nervous system become engaged such that the reflex 432 hierarchy still maintains its capability to respond to stressors. 433
Clinical perspectives 434
Autonomic imbalance plays an important role in the genesis of cardiac arrhythmias and 435 progression of heart failure (21, 32, 51, 54). Sympathetic activation and parasympathetic 436 withdrawal is not only pro-arrhythmic (21), but also accelerates progression of heart failure (19, 437 30, 58, 60). Furthermore, heart failure patients with poor vagal tone are known to have a worse 438 prognosis (40). In animal models of chronic heart failure, VNS has been shown to decrease what is obvious from these ongoing trials is that VNS is safe and feasible in the setting of 450 reduced ejection fraction heart failure. Data from randomized, controlled studies are required toelucidate the impact VNS on morbidity and mortality in patients with chronic heart failure 452
syndrome. 453
In view of the data presented herein, future studies should consider what is "subthreshold" 454 VNS. Multiple studies have recently evaluated the effects of low-level VNS for treatment of atrial 455 arrhythmias and heart failure (49, 53). What is obvious from data presented herein is that 456 central and peripheral elements of the hierarchy for cardiac control become engaged by output 457 current levels well below those current density applications that suppress chronotropism. Thus, 458 these data lead us to propose that: 1) the chronic effects of vagus nerve stimulation therapy rest 459 primarily on the indirect pathways that target intrinsic cardiac LCNs; and 2) that the optimal VNS 460 stimulus parameters are coincident with the neural fulcrum (31). Future studies on the efficacy 461 of VNS therapy for heart failure should focus on optimization of stimulation parameters, while 462 focusing on patient selection and therapeutic transition where indicated in the standard of care. 463
As such, future preclinical and clinical studies should be designed to employ the entire cardiac 464 nervous system in order to achieve long-term therapeutic benefits while minimizing off-target 465 side effects of VNS. 
